NLRP3炎症小体介导的IL-1β依赖反应在重症激素抵抗性哮喘中的作用
该研究利用衣原体和流感嗜血杆菌感染介导的卵清蛋白诱导小鼠模型,探讨NLRP3炎症小体及IL-1β在重症激素抵抗性哮喘中的作用。结果显示感染增强NLRP3、caspase-1和IL-1β反应,驱动激素抵抗性中性粒细胞炎症和气道高反应性;抑制这些通路可减轻疾病特征,提示NLRP3炎症小体是潜在治疗靶点。
要点
- 重症激素抵抗性哮喘小鼠模型中NLRP3炎症小体和IL-1β反应增强。
- 抑制NLRP3、caspase-1或中和IL-1β可减轻激素抵抗特征。
- 中性粒细胞清除可抑制IL-1β诱导的激素抵抗性气道高反应性。
核心结论
- NLRP3炎症小体反应驱动实验性重症激素抵抗性哮喘,是潜在治疗靶点。
研究设计与样本
- 研究建立衣原体和流感嗜血杆菌呼吸道感染介导的卵清蛋白诱导小鼠重症激素抵抗性过敏性气道疾病模型。
主要发现
- 衣原体和流感嗜血杆菌感染增加NLRP3、caspase-1和IL-1β反应,驱动激素抵抗性中性粒细胞炎症和气道高反应性。
- 人哮喘患者的中性粒细胞气道炎症、疾病严重程度和激素抵抗与NLRP3和IL-1β表达相关。
- 抗IL-1β抗体、Ac-YVAD-cho和MCC950抑制IL-1β反应及小鼠激素抵抗特征,而给予IL-1β可重现这些特征。
- 中性粒细胞清除抑制IL-1β诱导的激素抵抗性气道高反应性。
临床怎么用
- 针对NLRP3炎症小体、caspase-1或IL-1β可能成为重症激素抵抗性哮喘的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Severe, steroid-resistant asthma is the major unmet need in asthma therapy. Disease heterogeneity and poor understanding of pathogenic mechanisms hampers the identification of therapeutic targets. Excessive nucleotide-binding oligomerization domain-like receptor family, pyrin domain-containing 3 (NLRP3) inflammasome and concomitant IL-1β responses occur in chronic obstructive pulmonary disease, respiratory infections, and neutrophilic asthma. However, the direct contributions to pathogenesis, mechanisms involved, and potential for therapeutic targeting remain poorly understood, and are unknown in severe, steroid-resistant asthma. OBJECTIVES: To investigate the roles and therapeutic targeting of the NLRP3 inflammasome and IL-1β in severe, steroid-resistant asthma. METHODS: We developed mouse models of Chlamydia and Haemophilus respiratory infection-mediated, ovalbumin-induced severe, steroid-resistant allergic airway disease. These models share the hallmark features of human disease, including elevated airway neutrophils, and NLRP3 inflammasome and IL-1β responses. The roles and potential for targeting of NLRP3 inflammasome, caspase-1, and IL-1β responses in experimental severe, steroid-resistant asthma were examined using a highly selective NLRP3 inhibitor, MCC950; the specific caspase-1 inhibitor Ac-YVAD-cho; and neutralizing anti-IL-1β antibody. Roles for IL-1β-induced neutrophilic inflammation were examined using IL-1β and anti-Ly6G. MEASUREMENTS AND MAIN RESULTS: Chlamydia and Haemophilus infections increase NLRP3, caspase-1, IL-1β responses that drive steroid-resistant neutrophilic inflammation and airway hyperresponsiveness. Neutrophilic airway inflammation, disease severity, and steroid resistance in human asthma correlate with NLRP3 and IL-1β expression. Treatment with anti-IL-1β, Ac-YVAD-cho, and MCC950 suppressed IL-1β responses and the important steroid-resistant features of disease in mice, whereas IL-1β administration recapitulated these features. Neutrophil depletion suppressed IL-1β-induced steroid-resistant airway hyperresponsiveness. CONCLUSIONS: NLRP3 inflammasome responses drive experimental severe, steroid-resistant asthma and are potential therapeutic targets in this disease.
引用
- Kim RY, Pinkerton JW, Essilfie AT, et al. Role for NLRP3 Inflammasome-mediated, IL-1β-Dependent Responses in Severe, Steroid-Resistant Asthma. Am J Respir Crit Care Med. 2017. PMID: 28252317. doi:10.1164/rccm.201609-1830OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。